Table 1

Included studies reporting endpoints of interest

Study (reference)CountryTrial datesModified Jadad*Potential for biasHospital settingDepth of sedationSedativeMonitoring staffOxygen at baselineN
(control, Cap)
Beitz et al 28 Germany10 February, 11 January5.5High: 3Colonoscopy‘adequate’PropofolNot specified2 L/min757 (374, 383)
Deitch et al 26 USA6 November, 8 February5.5Low: 0Emergency departmentModeratePropofolNot specified3 L/min132 (64, 68)
Friedrich-Rust et al 29 Germany12 June, 13 May6Low: 0ColonoscopyDeepPropofol†Anaesthesiologist or sedation-trained nurse2 L/min533 (266, 267)
Langhan et al 31 USA11 September, 13 January6Low: 0Paediatric emergency departmentNAKetamine, midazolam‘Treating staff’None154 (77, 77)
Lightdale et al 6 USA3 December, 4 November8Low: 0EndoscopyModerateFentanyl, midazolamIndependent observer2 L/min163 (80, 83)
Qadeer et al 5 USA7 January, 8 May7.5Moderate: 1ERCP and EUSNAMidazolam†Independent observerNone247 (124, 123)
Slagelse et al 32 Denmark10 September, 11 January6Low: 0EndoscopyNAPropofolSedation-trained nurse2–3 L/min540 (277, 263)
van Loon et al 27 Netherlands10 April, 11 January5Low: 0GynaecologyDeepPropofolMedical team providing sedationNone415 (209, 206)
Zongming et al 30 China10 November, 13 May6Low: 0AbortionDeepPropofolAnaesthesiologist3 L/min700 (359, 341)
Campbell et al 49 Canada6 April, 12 April5Moderate: 2Emergency departmentNAPhysician’s choiceParamedic acute care practitioner98.7% received oxygen986 (501, 485)
Klare et al 34 Germany10 February, 11 October5.5Moderate: 1ERCPDeepMidazolam and propofolPhysician not performing procedure2 L/min238 (117, 121)
Mehta et al 25 USA13 December, 15 January8Low: 0ColonoscopyModerateFentanyl or meperidine, plus midazolamIndependent observerNone231 (114, 117)
Mehta et al 25 USA13 December, 15 January8Low: 0EGDModerateFentanyl or meperidine, plus midazolamIndependent observerNone209 (108, 101)
Riphaus et al 33 Germany10 June, 11 November5.5High: 3EUS‘adequate’Midazolam and propofolIndependent observer2 L/min170 (87, 83)
  • *Higher scores indicate higher quality studies. In the present analysis, a score of 6.0–8.0 was designated as high quality.

  • †In combination with multiple other agents.

  • Cap, capnography (arm); EGD, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasonography; NA, not applicable.